Biological Therapy Analysis & Statistics, September 2014 (p2)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: Flow Cytometry, Hematology, Stem Cell, more »

31-60 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

BioHeart, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

BioHeart, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
BIONET Corp. (Symbol:1784) SWOT Analysis, Strategy, Revenues and Profits

BIONET Corp. (Symbol:1784) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Taiwan
Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Genitope Corporation (Genitope) is a publicly held US based biotechnology company. It is focused on the research and development (R&D) of novel immunotherapies for the treatment of cancer. The ...

  • Industries : Biological Therapy
  • Countries : United States
Chemokine Therapeutics Corp. (CTI) - Strategic SWOT Analysis Review

Chemokine Therapeutics Corp. (CTI) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Chemokine Therapeutics Corp. (Chemokine Therapeutics) is a publicly held biotechnology company. It is engaged in the discovery and develops peptide analogs of chemokines for cancer treatment and ...

  • Industries : Biological Therapy
  • Countries : Canada, United Kingdom
Japan Tissue Engineering Co., Ltd. (Symbol:7774) SWOT Analysis, Strategy, Revenues and Profits

Japan Tissue Engineering Co., Ltd. (Symbol:7774) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Japan
MediPost Co., Ltd. (Symbol:078160) SWOT Analysis, Strategy, Revenues and Profits

MediPost Co., Ltd. (Symbol:078160) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Cellectis S.A. (Symbol:ALCLS) SWOT Analysis, Strategy, Revenues and Profits

Cellectis S.A. (Symbol:ALCLS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
GENova Biotherapeutics, Inc. (Symbol:GVBP) SWOT Analysis, Strategy, Revenues and Profits

GENova Biotherapeutics, Inc. (Symbol:GVBP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
Nkbio Co., Ltd. (Symbol:019260) SWOT Analysis, Strategy, Revenues and Profits

Nkbio Co., Ltd. (Symbol:019260) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : South Korea
Optimer Pharmaceuticals, Inc. (Symbol:OPTR) SWOT Analysis, Strategy, Revenues and Profits

Optimer Pharmaceuticals, Inc. (Symbol:OPTR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Protokinetix Inc. (Symbol:PKTX) SWOT Analysis, Strategy, Revenues and Profits

Protokinetix Inc. (Symbol:PKTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Canada
ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Viropro Inc. (Symbol:VPRO) SWOT Analysis, Strategy, Revenues and Profits

Viropro Inc. (Symbol:VPRO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
CHA Bio & Diostech Co., Ltd. (Symbol:085660) SWOT Analysis, Strategy, Revenues and Profits

CHA Bio & Diostech Co., Ltd. (Symbol:085660) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : South Korea
Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review

Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Mesoblast Limited (Mesoblast) is a biotechnology company. The company focuses on developing novel biotherapeutics using its cell-based technologies for the treatment of a wide range of diseases. ...

  • Industries : Biological Therapy
  • Countries : Australia, Singapore, United States
Stem Cell Innovations, Inc. (SCLL) - Strategic SWOT Analysis Review

Stem Cell Innovations, Inc. (SCLL) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Stem Cell Innovations, Inc. (SCI) is a privately held biotechnology company, based in the US. The company is engaged in the discovery and development of human cell based drugs. Its core technologies ...

  • Industries : Biological Therapy
  • Countries : United States
TiGenix NV (Symbol:TIG) SWOT Analysis, Strategy, Revenues and Profits

TiGenix NV (Symbol:TIG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Belgium, Spain
Tissue Therapies Limited (Symbol:TIS) SWOT Analysis, Strategy, Revenues and Profits

Tissue Therapies Limited (Symbol:TIS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Australia
AmStem Corporation (Symbol:AMST) SWOT Analysis, Strategy, Revenues and Profits

AmStem Corporation (Symbol:AMST) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy) is a regenerative medicine company. The company's services include cell therapy. Its cell therapy is developing a novel cell-based therapy ...

  • Industries : Biological Therapy
  • Countries : United States
Forticell Bioscience, Inc. - Strategic SWOT Analysis Review

Forticell Bioscience, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Forticell Bioscience, Inc. (Forticell) is a biotechnology company. The company develops natural biomaterials and tissue engineered cellular therapies. Its product OrCel is used to stimulate the ...

  • Industries : Biological Therapy
  • Countries : United States
Protide Pharmaceuticals, Inc. - Strategic SWOT Analysis Review

Protide Pharmaceuticals, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Protide Pharmaceuticals, Inc. (Protide) is a biotechnology company. The company develops and commercializes technologies and processes in clinical cell therapy, regenerative medicine, transfusion ...

  • Industries : Biological Therapy
  • Countries : United States
Pharmicell Co., Ltd. (005690) - Financial and Strategic SWOT Analysis Review

Pharmicell Co., Ltd. (005690) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Pharmicell Co., Ltd. (Pharmicell) is a biotechnology company. The company develops and commercializes stem cell therapeutics for incurable diseases such as cancer, brain and nervous system disorde ...

  • Industries : Biological Therapy
VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Vita 34 International AG (Vita 34) is a pharmaceutical company. The company collects, prepares, processes, and stores stem cells from umbilical cord blood. Its products include vitaplus, vitaplus25, ...

  • Industries : Biological Therapy
  • Countries : Switzerland
Medinet Co., Ltd. (2370) - Financial and Strategic SWOT Analysis Review

Medinet Co., Ltd. (2370) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Medinet Co., Ltd. (Medinet) is a biotechnology company. The company conducts business through the divisions such as immuno-cell therapy and research and development. Its immuno cell therapy total ...

  • Industries : Biological Therapy
  • Countries : Japan, Australia
Zeltia, S.A. (ZEL) - Financial and Strategic SWOT Analysis Review

Zeltia, S.A. (ZEL) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Zeltia, S.A. (Zeltia) is a pharmaceutical holding company. It operates through a group of companies in biopharmaceutical and chemical sectors. Under biopharmaceutical sector it discovers and develops ...

  • Industries : Biological Therapy
  • Countries : Spain, Italy

34 Companies

Read our Company Profiles

Bioheart Inc.

United States

StemCells Inc.

United States

Aastrom Biosciences Inc.

United States

Osiris Therapeutics Inc.

United States

Geron Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.